1-111697432-C-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_002884.4(RAP1A):c.127-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000042 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000063 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
RAP1A
NM_002884.4 intron
NM_002884.4 intron
Scores
2
Splicing: ADA: 0.00003369
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.155
Publications
0 publications found
Genes affected
RAP1A (HGNC:9855): (RAP1A, member of RAS oncogene family) This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. Pseudogenes of this gene have been defined on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
INKA2 (HGNC:28045): (inka box actin regulator 2) Enables protein kinase binding activity. Predicted to be involved in negative regulation of catalytic activity. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002884.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.0000423 AC: 6AN: 141984Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
141984
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000124 AC: 29AN: 234352 AF XY: 0.000141 show subpopulations
GnomAD2 exomes
AF:
AC:
29
AN:
234352
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000631 AC: 91AN: 1441990Hom.: 0 Cov.: 33 AF XY: 0.0000515 AC XY: 37AN XY: 717786 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
91
AN:
1441990
Hom.:
Cov.:
33
AF XY:
AC XY:
37
AN XY:
717786
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
8
AN:
31864
American (AMR)
AF:
AC:
40
AN:
40756
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
25386
East Asian (EAS)
AF:
AC:
0
AN:
39422
South Asian (SAS)
AF:
AC:
4
AN:
83792
European-Finnish (FIN)
AF:
AC:
6
AN:
52202
Middle Eastern (MID)
AF:
AC:
0
AN:
5622
European-Non Finnish (NFE)
AF:
AC:
24
AN:
1103566
Other (OTH)
AF:
AC:
4
AN:
59380
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.246
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000423 AC: 6AN: 141984Hom.: 0 Cov.: 31 AF XY: 0.0000435 AC XY: 3AN XY: 68906 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
6
AN:
141984
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
68906
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
37342
American (AMR)
AF:
AC:
0
AN:
14396
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3398
East Asian (EAS)
AF:
AC:
0
AN:
5022
South Asian (SAS)
AF:
AC:
0
AN:
4574
European-Finnish (FIN)
AF:
AC:
3
AN:
8826
Middle Eastern (MID)
AF:
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
AC:
3
AN:
65308
Other (OTH)
AF:
AC:
0
AN:
1940
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.233
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.